Inspire Medical Systems, Inc.
INSP· NYSE
INSPInspire Medical Systems, Inc.
Filed Feb 9, 2024 · 10-K · 40 days after period end · 0001609550-24-000016
derived · Computed from the longer spans the company filed.
| Metric | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020 |
|---|---|---|---|---|
| Revenue | $192.51M | $137.90M | $78.40M | $46.01M |
| Net Income | $14.76M | $3.15M | -$2.39M | -$7.48M |
| EPS Diluted | — | — |
Inspire Medical Systems, Inc. · CIK 1609550 · Engraved from SEC EDGAR
| — |
| -$0.28 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2023 · filed Feb 9, 2024 · 40 d after period end
